Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $27.1B
1-Year Return 23.24%
This Quarter Return
+13.58%
1 Year Return
+23.24%
3 Year Return
+64.59%
5 Year Return
+118.48%
10 Year Return
+210.79%
AUM
$17B
AUM Growth
+$1.79B
Cap. Flow
-$286M
Cap. Flow %
-1.68%
Top 10 Hldgs %
33.75%
Holding
1,485
New
138
Increased
706
Reduced
317
Closed
71

Sector Composition

1 Real Estate 60.4%
2 Technology 9.5%
3 Consumer Discretionary 4.17%
4 Communication Services 4.01%
5 Financials 3.46%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
IMRX icon
1301
Immuneering
IMRX
$233M
$1K ﹤0.01%
+76
New +$1K
KALV icon
1302
KalVista Pharmaceuticals
KALV
$773M
$1K ﹤0.01%
46
KMDA icon
1303
Kamada
KMDA
$411M
$1K ﹤0.01%
84
KNSA icon
1304
Kiniksa Pharmaceuticals
KNSA
$2.65B
$1K ﹤0.01%
60
KPTI icon
1305
Karyopharm Therapeutics
KPTI
$57.8M
$1K ﹤0.01%
9
KZR icon
1306
Kezar Life Sciences
KZR
$29.8M
$1K ﹤0.01%
9
MIRM icon
1307
Mirum Pharmaceuticals
MIRM
$3.83B
$1K ﹤0.01%
+89
New +$1K
NRXP icon
1308
NRX Pharmaceuticals
NRXP
$63.9M
$1K ﹤0.01%
+17
New +$1K
OLMA icon
1309
Olema Pharmaceuticals
OLMA
$563M
$1K ﹤0.01%
+118
New +$1K
OMER icon
1310
Omeros
OMER
$284M
$1K ﹤0.01%
214
PAHC icon
1311
Phibro Animal Health
PAHC
$1.59B
$1K ﹤0.01%
38
PASG icon
1312
Passage Bio
PASG
$22.3M
$1K ﹤0.01%
9
PRLD icon
1313
Prelude Therapeutics
PRLD
$66.8M
$1K ﹤0.01%
+104
New +$1K
QNCX icon
1314
Quince Therapeutics
QNCX
$85.9M
$1K ﹤0.01%
102
RANI icon
1315
Rani Therapeutics
RANI
$23.8M
$1K ﹤0.01%
+58
New +$1K
RIGL icon
1316
Rigel Pharmaceuticals
RIGL
$728M
$1K ﹤0.01%
37
RLMD icon
1317
Relmada Therapeutics
RLMD
$53.8M
$1K ﹤0.01%
31
RLYB icon
1318
Rallybio
RLYB
$24.8M
$1K ﹤0.01%
+94
New +$1K
RNAC icon
1319
Cartesian Therapeutics
RNAC
$274M
$1K ﹤0.01%
7
SABS icon
1320
SAB Biotherapeutics
SABS
$23.1M
$1K ﹤0.01%
+13
New +$1K
SIGA icon
1321
SIGA Technologies
SIGA
$600M
$1K ﹤0.01%
172
SMMT icon
1322
Summit Therapeutics
SMMT
$19.1B
$1K ﹤0.01%
334
STTK icon
1323
Shattuck Labs
STTK
$72.8M
$1K ﹤0.01%
+123
New +$1K
TSHA icon
1324
Taysha Gene Therapies
TSHA
$897M
$1K ﹤0.01%
+112
New +$1K
VOR icon
1325
Vor Biopharma
VOR
$250M
$1K ﹤0.01%
+109
New +$1K